
National Association of Testing Authorities, Australia
Scope of Accreditation
Fulgent Australia
Site
Fulgent Australia
Accreditation No.
21575
Site No.
25984
Date of Accreditation
11 Sep 2025
Contact
Dr Carol Siu P: +61 (08) 83187019
Availability
Services not available to external clients
Supervision
GX (General)
Scope of Accreditation
Fulgent Australia
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Molecular genetics - DNA extraction | Blood; Buccal swabs | DNA storage for future analyses; Viable DNA for sequencing and other molecular assays |
Molecular genetics - DNA fragment size analysis | Blood; Buccal cells | Copy number variation (CNV) |
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood; Buccal swabs | Adrenoleukodystrophy (ALD); Cystic fibrosis transmembrane conductance regulator (CFTR); Duchenne-Becker muscular dystrophy; Fabry disease; Haemophilia A; Haemophilia B; Ornithine transcarbamylase deficiencyL1 syndrome; Opitz GBBB syndrome; X-linked adrenal hypoplasia congenita; Pelizaeus-Merzbacher disease/Spastic paraplegia type 2; Retinitis pigmentosa GTPase regulator-related; Cerebral creatine def |
Fragile X messenger ribonucleoprotein 1 (FMR1) related disorders | ||
Survival of motor neuron 1 (SMN1) | ||
Molecular genetics/Cytogenetics - Bioinformatic analysis | Alignment files; DNA sequences; FASTQ files; TXT files; VCF files | Secondary analysis - Alignment and variant calling; Tertiary analysis - Data interpretation |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
21575
Site No.
25984
Print date
14 Sep 2025
END OF SCOPE